Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
131
|
Mon, 7/29/2019,
8:30 AM -
10:20 AM
|
CC-101
|
Topics in Clinical Trials — Contributed Papers
|
Biopharmaceutical Section
|
Chair(s): Guanglei Yu, Eli Lilly and Company
|
8:35 AM
|
Methods for Evaluating Heterogeneity in Treatment Effects in a Randomized Clinical Trial
Alok Dwivedi, Texas Tech University Health Sciences Center El Paso; Muditha Perera, Texas Tech University Health Sciences Center El Paso; Sada Nand Dwivedi, All India Institute of Medical Sciences; Rakesh Shukla, University of Cincinnati
|
8:50 AM
|
Estimation of Treatment Effect in a Multi-Regional Clinical Trial with Survival Endpoint
Hsiao-Hui Tsou, National Health Research Institutes; Yu-Chieh Cheng, National Health Research Institutes; Yuh-Jeng Wu, Chung Yuan Christian University; Chin-Fu Hsiao, National Health Research Institutes
|
9:05 AM
|
Challenges of Filing Externally Conducted Clinical Trials
Kenneth Liu, Merck & Co., Inc; Jonathan Hartzel, Merck & Co., Inc
|
9:20 AM
|
An Integrative Shrinkage Estimator for Random-Effects Meta-Analysis of Rare Binary Events
Lie Li, Merck & Co.; Xinlei Wang, Southern Methodist University; Ou Bai, NA
|
9:35 AM
|
Exploring Heterogeneity of Treatment Response: Assumptions, Logic, Algorithm, Computations
Lev Sverdlov, Redmond Analytics, LLC
|
9:50 AM
|
Dynamic Data Monitoring for On-Going Clinical Trials
Tai Xie, Brightech International; Ping Gao, Brightech International; Peng Zhang, Brightech International; Yue Tu, Brightech International; Joe Shih, Rutgers University
|
10:05 AM
|
Blinded Safety Monitoring in Clinical Trials and IND Safety Reporting: Challenges and Lessons Learned
Barbara Hendrickson, AbbVie
|
|